Abstract

MicroRNAs are an emerging class of synaptic regulators. These small noncoding RNAs post-transcriptionally regulate gene expression, thereby altering neuronal pathways and shaping cell-to-cell communication. Their ability to rapidly alter gene expression and target multiple pathways makes them interesting candidates in the study of synaptic plasticity. Here, we demonstrate that the proconvulsive microRNA miR-324-5p regulates excitatory synapse structure and function in the hippocampus of mice. Both Mir324 knockout (KO) and miR-324-5p antagomir treatment significantly reduce dendritic spine density in the hippocampal CA1 subregion, and Mir324 KO, but not miR-324-5p antagomir treatment, shift dendritic spine morphology, reducing the proportion of thin, “unstable” spines. Western blot and quantitative Real-Time PCR revealed changes in protein and mRNA levels for potassium channels, cytoskeletal components, and synaptic markers, including MAP2 and Kv4.2, which are important for long-term potentiation (LTP). In line with these findings, slice electrophysiology revealed that LTP is severely impaired in Mir324 KO mice, while neurotransmitter release probability remains unchanged. Overall, this study demonstrates that miR-324-5p regulates dendritic spine density, morphology, and plasticity in the hippocampus, potentially via multiple cytoskeletal and synaptic modulators.

Details

Title
Mir324 knockout regulates the structure of dendritic spines and impairs hippocampal long-term potentiation
Author
Parkins, Emma V. 1 ; Brager, Darrin H. 2 ; Rymer, Jeffrey K. 3 ; Burwinkel, John M. 3 ; Rojas, Diego 3 ; Tiwari, Durgesh 4 ; Hu, Yueh-Chiang 5 ; Gross, Christina 4 

 University of Cincinnati Neuroscience Graduate Program, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Cincinnati Children’s Hospital Medical Center, Division of Neurology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099) 
 The University of Texas at Austin, Center for Learning and Memory, Department of Neuroscience, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924) 
 Cincinnati Children’s Hospital Medical Center, Division of Neurology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099) 
 University of Cincinnati Neuroscience Graduate Program, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Cincinnati Children’s Hospital Medical Center, Division of Neurology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593) 
 University of Cincinnati College of Medicine, Department of Pediatrics, Cincinnati, USA (GRID:grid.24827.3b) (ISNI:0000 0001 2179 9593); Cincinnati Children’s Hospital Medical Center, Transgenic Animal and Genome Editing Core Facility, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099); Cincinnati Children’s Hospital Medical Center, Division of Developmental Biology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099) 
Pages
21919
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2900474656
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.